Your Notifications
All done, no notifications

About Dr. Suleyman Uraz

  • Dr. Süleyman Uraz has established a strong career in the fields of gastroenterology, hepatology, and internal medicine.
  • His foundation for medical knowledge was laid in 1990 when he enrolled in Akdeniz University Faculty of Medicine.
  • Dr. Süleyman Uraz undertook specialized training in Internal Medicine at Cerrahpaşa Faculty of Medicine, completing his residency in 2001.
  • He expanded his expertise in gastroenterology-hepatology through additional specialization at Kocaeli University Faculty of Medicine in 2004.
  • This focused training enhanced his diagnostic and treatment capabilities for liver and gastrointestinal disorders, solidifying his proficiency in these critical medical fields.
  • Dr. Süleyman Uraz's thorough training and continued contributions to the fields of gastroenterology and hepatology demonstrate his commitment to improving medical knowledge and patient care.

Conditions treated by Dr. Süleyman Uraz

  • Irritable bowel syndrome (IBS).
  • Inflammatory bowel disease (IBD).
  • Celiac disease.
  • Small intestinal bacterial overgrowth (SIBO).
  • Food allergies and intolerances.
  • Stomach ulcers.
  • Diverticulitis.
  • Appendicitis.
  • Colorectal polyps.
  • Hemorrhoids.
  • Swallowing difficulties.
  • Gastroesophageal reflux disease (GERD).
  • Esophagitis.
  • Hiatal hernias.
  • Viral hepatitis.
  • Toxic hepatitis.
  • Fatty liver disease.
  • Cirrhosis.
  • Gallstones.
  • Cholecystitis.
  • Pancreatitis.
  • Hepatitis and Cirrhosis
  • Pancreatitis and Cholecystitis
  • Colitis and Cancers

Area of Interest

  • Colonoscopy
  • ERCP
  • Gall bladder
  • Gastroenterology

Qualification

  • 2004- Kocaeli University Faculty of Medicine
    Gastroenterology-Hepatology Minor Specialization
  • 2001- Cerrahpaşa Faculty of Medicine
    Internal Medicine Specialization Training
  • 1990- Akdeniz University Faculty of Medicine
    Medical Education
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

MEMBERSHIPS (4)

  • Turkish Gastroenterology Association
  • Hepato Bilio Pancreatology Association
  • Turkish Liver Research Association
  • Liver Transplant Association (Founding Member)

RESEARCH PAPERS AND PUBLICATIONS (20)

  • Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Danalioglu A, Avsar E, Turkoglu S, Midilli K, Tabak F, Ozturk R, Mert A, senturk H, Tozun N. Is HCV Genotyping Costeffective Even When the Prevalence of Genotypes 2 and 3 are Low? Hepato gastroenterology 2009;56:1425-8.
  • Duran C, Uraz S, Kantarci M, Ozturk E, Doganay S, Dayangac M, Bozkurt M, Yuzer Y, Tokat Y.Hepatic arterial mapping by multidetector computed tomographic angiography in living donor liver transplantation. J Comput Assist Tomogr. 2009;33(4):618-25.
  • Duran C, Oztürk E, Uraz S, Kocakuşak A, Mutlu H, Killi R. Midgut volvulus: the value of multidetector computed tomography in diagnosis. Turk J Gastroenterol. 2008;19(3):189-92.
  • Taner CB, Dayangac M, Akin B, Balci D, Uraz S, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y. Donor safety and remnant liver volume in living donor liver transplantation. Liver Transpl. 2008;14(8):1174.
  • Balci D, Taner B, Dayangac M, Akin B, Yaprak O, Duran C, Uraz S, Hayzaran S, Ayanoglu O, Killi R, Senturk H, Yuzer Y, Tokat Y. Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report. TransplantProc. 2008;40(5):1786-8.
  • Atug O, Giral A, Kalayci C, Dolar E, Isitan F, Oguz D, Ovunc O, Ozgur O, Soykan I, Simsek I, Unal S, Yenice N; Turkish HEMANEX Study Group. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study. Adv Ther. 2008;25(6):552-66.
  • Senturk H, Tahan V, Canbakan B, Uraz S, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G. Chronic hepatitis C responds poorly to combination therapy in chronic hepatitis B carriers. Neth J Med. 2008;66(5):191-5.
  • Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2008;53(5):1352-7.
  • Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M, Senturk O, Avsar E, Haklar G, Celikel C, Hulagu S, Tozun N. Role of ursodeoxycholic acid in the prevention of methotrexate-induced liver toxicity. Dig Dis Sci. 2008;53(4):1071-7.
  • Imeryuz N, Tahan V, Sonsuz A, Eren F, Uraz S, Yuksel M, Akpulat S, Ozcelik D, Haklar G, Celikel C, Avsar E, Tozun N. Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death. J Hepatol. 2007;47(6):851-9.
  • Tahan V, Tahan G, Dane F, Uraz S, Yardim M. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis. 2007;16(2):224-5.
  • Uraz S, Duran C, Balci D, Akin B, Dayangac M, Kurt Z, Ayanoglu OH, Killi R, Yuzer Y, Tokat Y. A very rare venous anomaly in a living liver donor: left hepatic venous connection to the right atrium. TransplantProc. 2007;39(5):1714-5.
  • Uraz S, Aygün C, Konduk T, Celebi A, Sentürk O, Hülagü S. A rare gastric outlet anomaly: pyloric ostium on incisura angular. Dig Dis Sci. 2007;52(4):1001-3.
  • Aygun C, Senturk O, Hulagu S, Uraz S, Celebi A, Konduk T, Mutlu B, Canturk Z. Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2006;18(2):175-80.
  • Aygun C, Uraz S, Damci T, Osar Z, Yumuk V, Akdenizli E, Ilkova H. Celiac disease in an adult Turkish population with type 1 diabetes mellitus. Dig Dis Sci. 2005;50(8):1462-6.
  • Uraz S, Aygun C, Sonsuz A, Ozbay G. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis. Dig Dis Sci. 2005;50(5):964-9.
  • Sivri B, Simsek I, Hulagu S, Kadayifci A, Tozun N, Akarsu M, Uraz S, Savas MC, Koruk M, Bozbas A. The efficacy, safety, and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing. Curr Med Res Opin. 2004;20(8):1301-7.
  • Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, Avsar E, Ozbay G, Celikel CA, Tozun N, Senturk H. The prevalence of hepatic granulomas in chronic hepatitis C. J Clin Gastroenterol. 2004;38(5):449-52.
  • Ozaras R, Mert A, Tahan V, Uraz S, Ozaydin I, Yilmaz MH, Ozaras N. Ciprofloxacin and Achilles’ tendon rupture: a causal relationship. Clin Rheumatol. 2003;22(6):500-1.
  • Ozaras R, Yilmaz MH, Tahan V, Uraz S, Yigitbasi R, Senturk H. Spontaneous hematoma of the rectus abdominis muscle: a rare cause of acute abdominal pain in the elderly. Acta Chir Belg. 2003;103(3):332-3.

Share Your Experience about Dr. Suleyman Uraz

PROCEDURES

  • Adhesion Lysis
  • Capsule Endoscopy
  • Cardiomyotomy
  • Foregut Surgery
  • Hiatal Hernia Repair
  • Ileoanal Anastomosis (J-Pouch) Surgery
  • Laparoscopic Colon Resection
  • Laparoscopic Ventral Hernia Repair
  • Low Anterior Resection
  • Meckel's Diverticulectomy Treatment
  • Nissen Fundoplication
  • Pancreatectomy
  • Pancreatic Surgery
  • Partial Colectomy
  • Peroral Endoscopic Myotomy (POEM)
  • Proctectomy
  • Retroperitoneum Surgery
  • Robotic Hernia Surgery
  • Small Bowel Resection
  • Splenectomy
  • Stapled Hemorrhoidopexy
  • Subtotal Proctocolectomy
  • Total Colectomy

FREQUENTLY ASKED QUESTIONS

Q: Is Doctor Suleyman Uraz doing teleconsultation on the MediGence platform?

A. Dr. Suleyman Uraz is available to teleconsultate on the MediGence platform.

Q: How long is the consultation?

A. The consultation can last up to 15 to 30 minutes. It may go beyond the estimated time which is dependent on the patient’s queries and the medical suggestions of the doctor.

Q: How soon can the consultation be organized?

A. We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organized within 24 to 48 hours or based on the availability of the doctor and the patient.

Q: Is follow-up consultation included in the consultation price?

A. No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

Q: How do I share my medical record with the doctor for review?

A. The option to share your medical records is available between the steps of the form provided to you on the website.

Q: Can I book my procedure with the doctor post-consultation?

A. Yes. If you are satisfied with the consultation, then you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Q: Is it possible to get the estimate for the procedure?

A. Yes. The cost estimate will be provided to you by our case manager including the doctor’s opinion, the cost estimate, and the crucial information about traveling to your medical destination.

Reviewer

Dr. Vihan Gautam
Dr. Vihan Gautam

BPT, MS in Healthcare Mgmt

4 Years of Experience

Dr. Vihan Gautam is a distinguished Rehabilitation Specialist and Healthcare Management Professional, holding a Bachelor of Physiotherapy (BPT) from Rajiv Gandhi University of Health Sciences and a Master of Science in Healthcare Management (MSc) from the prestigious University of London, United Kingdom.With specialized clinical experience and his advanced medical knowledge in neuro-rehabilitation, musculoskeletal disorders, and evidence-based physiotherapy practices, enables him to develop patient-centered rehabilitation protocols and AI-driven care models that deliver measurable functional recovery outcomes. His diverse contributions across international rehabilitation programs, multidisciplinary care, and AI-driven healthcare initiatives uniquely position him as an emerging leader in neuro-rehabilitative care globally. View More

Last Reviewed - January 2026

Author

Alvina Hasan
Alvina Hasan

M.Pharm

2 Year of Experience

Alvina Hasan is a dedicated medical researcher and scientific writer with a strong foundation in pharmaceutical sciences. She holds a B.Pharm from Jamia Hamdard University and an M.Pharm in Quality Assurance from DIPSAR University.

With deep medical expertise and a strong interest in healthcare communication, she focuses on transforming complex clinical and scientific information into clear, engaging, and easy-to-understand narratives. She develops insightful healthcare articles and research-driven content designed to support both medical professionals and patients, helping bridge the gap between advanced medical knowledge and practical understanding.

Readers can explore her published research and articles here:

https://carcinogenesis.com/index.php/JOC/article/view/868

https://carcinogenesis.com/index.php/JOC/article/view/870

. View More